Revenue
18 thousand USD
2027 Q1 · USD
Exact inputs and evidence
- Revenue: 18000 USD Source
Fundies. English
Organovo Holdings, Inc.
EDGARAnnual consolidated revenue for 2026: about USD 131K, using the latest reported figures. The previous period, 2025, was about USD 144K.
Latest quarter
Operating margin
-15,327.78%
2027 Q1 · %
Operating cash flow
-3.2 million USD
2027 Q1 · USD
Exact inputs and evidence
- Operating Cash Flow: -3200000 USD Source
Free cash flow
-3.22 million USD
2027 Q1 · USD
- Cash and cash equivalents
- 1.7 million USD Source
Exact value
1700000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 3.19 million shares Source
Exact value
3194295 shares
Reported share-count change
22.87% · 594 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
112 thousand USD
2025-07-01 – 2026-06-30
Net income
-12.3 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-10.1 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -6300000 USD · 2025-04-01 – 2025-09-30 Source
- Operating cash flow: -3940000 USD · 2025-04-01 – 2025-06-30 Source
- Operating cash flow: -8600000 USD · 2025-04-01 – 2025-12-31 Source
- Operating cash flow: -6300000 USD · 2025-04-01 – 2025-09-30 Source
- Operating cash flow: -10800000 USD · 2025-04-01 – 2026-03-31 Source
- Operating cash flow: -8600000 USD · 2025-04-01 – 2025-12-31 Source
- Operating cash flow: -3200000 USD · 2026-04-01 – 2026-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-16.
Financial data available through: 2026-03-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2026-03-31
- Operating income: 11 of 11 periods available· newest 2026-03-31
- Net income: 11 of 11 periods available· newest 2026-03-31
- Operating cash flow: 11 of 11 periods available· newest 2026-03-31
- Capital expenditure: 11 of 11 periods available· newest 2026-03-31
- Total assets: 11 of 11 periods available· newest 2026-03-31
- Total liabilities: 11 of 11 periods available· newest 2026-03-31
- Current assets: 11 of 11 periods available· newest 2026-03-31
- Current liabilities: 11 of 11 periods available· newest 2026-03-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2026-03-31
- long term debt: No compatible figures in this window
- Shares outstanding: 11 of 11 periods available· newest 2026-03-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
-9%Prior period
USD 144,000
–
Current period
USD 131,000
–
Exact inputs and evidence
131000 − 144000 = -13000 USD
144000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source131000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 11.36 millionPrior period
−USD 2.49 million
–
Current period
−USD 13.84 million
–
Exact inputs and evidence
-13843000 − -2488000 = -11355000 USD
-2488000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-13843000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.34 millionPrior period
−USD 9.46 million
–
Current period
−USD 10.8 million
–
Exact inputs and evidence
-10800000 − -9461000 = -1339000 USD
-9461000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-10800000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%Prior period
USD 13,000
–
Current period
USD 0
–
Exact inputs and evidence
0 − 13000 = -13000 USD
13000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source0 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2026 2025-04-01 – 2026-03-31
- Revenue USD 131,000 100% of revenue
- Cost of revenue USD 0 0% of revenue
- Operating expenses USD 11.62 million 8,869% of revenue
- Operating income −USD 11.49 million −8,769% of revenue
- Tax, interest and other Derived USD 2.36 million 1,798% of revenue
- Net income −USD 13.84 million −10,567% of revenue
Cash
- Operating cash flow −USD 10.8 million −8,244% of revenue
- Capital expenditure USD 0 0% of revenue
- Free cash flow Derived −USD 10.8 million −8,244% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Operating loss: operating costs were 1,012% of revenue.
- 2018 Operating loss: operating costs were 866% of revenue.
- 2019 Operating loss: operating costs were 982% of revenue.
- 2020 Operating loss: operating costs were 1,078% of revenue.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Operating loss: operating costs were 865% of revenue.
- 2023 Operating loss: operating costs were 4,892% of revenue.
- 2024 Operating loss: operating costs were 13,940% of revenue.
- 2025 Operating loss: operating costs were 8,861% of revenue.
- 2026 Operating loss: operating costs were 8,869% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2016-04-01 – 2017-03-31 | 4230000 | 42805000 Derived | -38575000 | -128000 Derived | -38447000 | -30539000 Derived | Source
|
| 2018 2017-04-01 – 2018-03-31 | 4603000 | 39874000 Derived | -35271000 | -468000 Derived | -34803000 | -29083000 Derived | Source
|
| 2019 2018-04-01 – 2019-03-31 | 3091000 | 30365000 Derived | -27274000 | -639000 Derived | -26635000 | -20454000 Derived | Source
|
| 2020 2019-04-01 – 2020-03-31 | 2196000 | 23671000 Derived | -21475000 | -2765000 Derived | -18710000 | -14882000 Derived | Source
|
| 2021 2020-04-01 – 2021-03-31 | 0 | 16826000 Derived | -16826000 | 0 Derived | -16826000 | -13728000 Derived | Source
|
| 2022 2021-04-01 – 2022-03-31 | 1500000 | 12979000 Derived | -11479000 | -31000 Derived | -11448000 | -8862000 Derived | Source
|
| 2023 2022-04-01 – 2023-03-31 | 370000 | 18101000 Derived | -17731000 | -472000 Derived | -17259000 | -12804000 Derived | Source
|
| 2024 2023-04-01 – 2024-03-31 | 109000 | 15195000 Derived | -15086000 | -415000 Derived | -14671000 | -14695000 Derived | Source
|
| 2025 2024-04-01 – 2025-03-31 | 144000 | 12760000 Derived | -12616000 | -10128000 Derived | -2488000 | -9474000 Derived | Source
|
| 2026 2025-04-01 – 2026-03-31 | 131000 | 11618000 Derived | -11487000 | 2356000 Derived | -13843000 | -10800000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 131K 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Revenue | 4230000 |
|
| 2018 | Revenue | 4603000 |
|
| 2019 | Revenue | 3091000 |
|
| 2020 | Revenue | 2196000 |
|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 1500000 |
|
| 2023 | Revenue | 370000 |
|
| 2024 | Revenue | 109000 |
|
| 2025 | Revenue | 144000 |
|
| 2026 | Revenue | 131000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
-9% 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Year over year | 185.2% |
|
| 2018 | Year over year | 8.8% |
|
| 2019 | Year over year | -32.8% |
|
| 2020 | Year over year | -29% |
|
| 2021 | Year over year | -100% |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | -75.3% |
|
| 2024 | Year over year | -70.5% |
|
| 2025 | Year over year | 32.1% |
|
| 2026 | Year over year | -9% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -8,768.7% 2026
Net margin -10,567.2% 2026
Free cash flow margin -8,244.3% 2026
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Operating margin | -911.9% |
|
| 2018 | Operating margin | -766.3% |
|
| 2019 | Operating margin | -882.4% |
|
| 2020 | Operating margin | -977.9% |
|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | -765.3% |
|
| 2023 | Operating margin | -4,792.2% |
|
| 2024 | Operating margin | -13,840.4% |
|
| 2025 | Operating margin | -8,761.1% |
|
| 2026 | Operating margin | -8,768.7% |
|
| 2017 | Net margin | -908.9% |
|
| 2018 | Net margin | -756.1% |
|
| 2019 | Net margin | -861.7% |
|
| 2020 | Net margin | -852% |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | -763.2% |
|
| 2023 | Net margin | -4,664.6% |
|
| 2024 | Net margin | -13,459.6% |
|
| 2025 | Net margin | -1,727.8% |
|
| 2026 | Net margin | -10,567.2% |
|
| 2017 | Free cash flow margin | -722% |
|
| 2018 | Free cash flow margin | -631.8% |
|
| 2019 | Free cash flow margin | -661.7% |
|
| 2020 | Free cash flow margin | -677.7% |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | -590.8% |
|
| 2023 | Free cash flow margin | -3,460.5% |
|
| 2024 | Free cash flow margin | -13,481.7% |
|
| 2025 | Free cash flow margin | -6,579.2% |
|
| 2026 | Free cash flow margin | -8,244.3% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -10.8M 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Operating cash flow | -29185000 |
|
| 2018 | Operating cash flow | -28857000 |
|
| 2019 | Operating cash flow | -20375000 |
|
| 2020 | Operating cash flow | -14882000 |
|
| 2021 | Operating cash flow | -13323000 |
|
| 2022 | Operating cash flow | -8453000 |
|
| 2023 | Operating cash flow | -12408000 |
|
| 2024 | Operating cash flow | -14653000 |
|
| 2025 | Operating cash flow | -9461000 |
|
| 2026 | Operating cash flow | -10800000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -10.8M 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Free cash flow | -30539000 |
|
| 2018 | Free cash flow | -29083000 |
|
| 2019 | Free cash flow | -20454000 |
|
| 2020 | Free cash flow | -14882000 |
|
| 2021 | Free cash flow | -13728000 |
|
| 2022 | Free cash flow | -8862000 |
|
| 2023 | Free cash flow | -12804000 |
|
| 2024 | Free cash flow | -14695000 |
|
| 2025 | Free cash flow | -9474000 |
|
| 2026 | Free cash flow | -10800000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
114.9% 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Liabilities / assets | 9.9% |
|
| 2018 | Liabilities / assets | 10.5% |
|
| 2019 | Liabilities / assets | 10.6% |
|
| 2020 | Liabilities / assets | 6.4% |
|
| 2021 | Liabilities / assets | 1.8% |
|
| 2022 | Liabilities / assets | 9.3% |
|
| 2023 | Liabilities / assets | 24.5% |
|
| 2024 | Liabilities / assets | 43.3% |
|
| 2025 | Liabilities / assets | 28.4% |
|
| 2026 | Liabilities / assets | 114.9% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
2.38× 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Current assets / current liabilities | 10.83× |
|
| 2018 | Current assets / current liabilities | 10.04× |
|
| 2019 | Current assets / current liabilities | 10.32× |
|
| 2020 | Current assets / current liabilities | 15.65× |
|
| 2021 | Current assets / current liabilities | 53.26× |
|
| 2022 | Current assets / current liabilities | 21.35× |
|
| 2023 | Current assets / current liabilities | 4.64× |
|
| 2024 | Current assets / current liabilities | 2.12× |
|
| 2025 | Current assets / current liabilities | 3.25× |
|
| 2026 | Current assets / current liabilities | 2.38× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2016-04-01 – 2017-03-31 | −USD 38.45 million Exact valueExact value: -38447000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 29.19 million Exact valueExact value: -29185000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.35 million Exact valueExact value: 1354000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.54 million Calculation and evidence-29185000 − 1354000 USD Exact free cash flow: -30539000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2017-04-01 – 2018-03-31 | −USD 34.8 million Exact valueExact value: -34803000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 28.86 million Exact valueExact value: -28857000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 226,000 Exact valueExact value: 226000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 29.08 million Calculation and evidence-28857000 − 226000 USD Exact free cash flow: -29083000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2018-04-01 – 2019-03-31 | −USD 26.64 million Exact valueExact value: -26635000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20.38 million Exact valueExact value: -20375000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 79,000 Exact valueExact value: 79000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20.45 million Calculation and evidence-20375000 − 79000 USD Exact free cash flow: -20454000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2019-04-01 – 2020-03-31 | −USD 18.71 million Exact valueExact value: -18710000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.88 million Exact valueExact value: -14882000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.88 million Calculation and evidence-14882000 − 0 USD Exact free cash flow: -14882000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2020-04-01 – 2021-03-31 | −USD 16.83 million Exact valueExact value: -16826000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.32 million Exact valueExact value: -13323000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 405,000 Exact valueExact value: 405000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.73 million Calculation and evidence-13323000 − 405000 USD Exact free cash flow: -13728000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-04-01 – 2022-03-31 | −USD 11.45 million Exact valueExact value: -11448000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.45 million Exact valueExact value: -8453000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 409,000 Exact valueExact value: 409000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.86 million Calculation and evidence-8453000 − 409000 USD Exact free cash flow: -8862000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-04-01 – 2023-03-31 | −USD 17.26 million Exact valueExact value: -17259000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.41 million Exact valueExact value: -12408000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 396,000 Exact valueExact value: 396000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.8 million Calculation and evidence-12408000 − 396000 USD Exact free cash flow: -12804000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-04-01 – 2024-03-31 | −USD 14.67 million Exact valueExact value: -14671000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.65 million Exact valueExact value: -14653000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 42,000 Exact valueExact value: 42000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.7 million Calculation and evidence-14653000 − 42000 USD Exact free cash flow: -14695000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-04-01 – 2025-03-31 | −USD 2.49 million Exact valueExact value: -2488000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.46 million Exact valueExact value: -9461000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 13,000 Exact valueExact value: 13000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.47 million Calculation and evidence-9461000 − 13000 USD Exact free cash flow: -9474000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-04-01 – 2026-03-31 | −USD 13.84 million Exact valueExact value: -13843000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.8 million Exact valueExact value: -10800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.8 million Calculation and evidence-10800000 − 0 USD Exact free cash flow: -10800000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
88 filings · 4,665 latest values · 4,665 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001497253, 1497253, ONVO, VIVS, edgar:1497253
Also known as ORGANOVO HOLDINGS, INC., Organovo Holdings, Inc., REAL ESTATE RESTORATION & RENTAL, INC., VIVOSIM LABS, INC, VIVOSIM LABS, INC., VivoSim Labs, INC., VivoSim Labs, Inc.